{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:19:40Z","timestamp":1776701980242,"version":"3.51.2"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1093\/jac\/43.1.113","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:41:00Z","timestamp":1027723260000},"page":"113-118","source":"Crossref","is-referenced-by-count":54,"title":["The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis"],"prefix":"10.1093","volume":"43","author":[{"given":"Karin","family":"Leder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Turnidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony M .","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Lindsay","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,1]]},"reference":[{"key":"key\n\t\t\t\t20170411035156_R1","unstructured":"Patel, K. B., Nicolau, D. P., Nightingale, C. H. & Quintiliani, R. 1995 Continuous-infusion of \u03b2-lactam antibiotics: a rational dosing approach. Connecticut Medicine59, 471\u20133."},{"key":"key\n\t\t\t\t20170411035156_R2","doi-asserted-by":"crossref","unstructured":"Visser, L. G., Arnouts, P., van Furth, R., Mattie, H. & van den Broek, P. J. 1993 Clinical pharmacokinetics of continuous intravenous administration of penicillins. Clinical Infectious Diseases17, 491\u20135.","DOI":"10.1093\/clinids\/17.3.491"},{"key":"key\n\t\t\t\t20170411035156_R3","doi-asserted-by":"crossref","unstructured":"Turnidge, J. D. 1998 The pharmacodynamics of \u03b2-lactams. Clinical Infectious Diseases27, 10\u201322.","DOI":"10.1086\/514622"},{"key":"key\n\t\t\t\t20170411035156_R4","doi-asserted-by":"crossref","unstructured":"Craig, W. A. & Ebert, S. C. 1992 Continuous-infusion of \u03b2-lactam antibiotics. Antimicrobial Agents and Chemotherapy 36, 2577\u201383.","DOI":"10.1128\/AAC.36.12.2577"},{"key":"key\n\t\t\t\t20170411035156_R5","unstructured":"Scheld, W. M. & Sande, M. A. (1995). Endocarditis and intravascular infections. In Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 740\u201383. Churchill Livingstone, Edinburgh."},{"key":"key\n\t\t\t\t20170411035156_R6","unstructured":"Kloos, W. E. & Bannerman, T. L. (1995). Staphylococcus and Micrococcus. In Manual of Clinical Microbiology, 6th edn, (Murray. P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 282\u201398. ASM Press, Washington, DC."},{"key":"key\n\t\t\t\t20170411035156_R7","unstructured":"National Committee for Clinical Laboratory Standards. (1993). Performance Standards for Antimicrobial Disk Susceptibilty Tests\u2014Sixth Edition: Document M2-A6. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411035156_R8","unstructured":"Trissel, L. A. (1996). Flucloxacillin sodium. In Handbook on Injectable Drugs, 9th edn, pp. 1134\u20138. American Society of Health-System Pharmacists, Bethesda, MD."},{"key":"key\n\t\t\t\t20170411035156_R9","unstructured":"Edberg, S. C. (1986). The measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 2nd edn, (Lorian, V., Ed), pp. 381\u2013514. Williams and Wilkins, Baltimore, MD."},{"key":"key\n\t\t\t\t20170411035156_R10","doi-asserted-by":"crossref","unstructured":"Fairley, C. K., McNeil, J. J., Desmond, P., Smallwood, R., Young, H., Forbes, A. et al. 1993 Risk factors for development of flucloxacillin associated jaundice. British Medical Journal 306, 233\u20135.","DOI":"10.1136\/bmj.306.6872.233"},{"key":"key\n\t\t\t\t20170411035156_R11","doi-asserted-by":"crossref","unstructured":"Olsson, R., Wiholm, B. E., Sand, C., Zettergren, L., Hultcrantz, R. & Myrhed, M.1992 Liver damage from flucloxacillin, cloxacillin and dicloxacillin. Journal of Hepatology15, 154\u201361.","DOI":"10.1016\/0168-8278(92)90029-O"},{"key":"key\n\t\t\t\t20170411035156_R12","doi-asserted-by":"crossref","unstructured":"Thauvin, C., Eliopoulos, G. M., Willey, S., Wennersten, C. & Moellering, R. C.1987 Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrobial Agents and Chemotherapy31, 139\u201343.","DOI":"10.1128\/AAC.31.2.139"},{"key":"key\n\t\t\t\t20170411035156_R13","unstructured":"Raber, S., Leggett, J., Kohlhepp, S., Dworkin, R. & Gilbert, D. (1996). Continuous versus intermittent infusion of oxacillin in patients with staphylococcal infections. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract A104, p. 20. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411035156_R14","doi-asserted-by":"crossref","unstructured":"Vondracek, T. G. 1995 \u03b2-Lactam antibiotics: is continuous infusion the preferred method of administration? Annals of Pharmacotherapy29, 415\u201324.","DOI":"10.1177\/106002809502900413"},{"key":"key\n\t\t\t\t20170411035156_R15","doi-asserted-by":"crossref","unstructured":"Craig, W. A. 1994 Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA. European Journal of Clinical Microbiology and Infectious Diseases14, 636\u201342.","DOI":"10.1007\/BF01690745"},{"key":"key\n\t\t\t\t20170411035156_R16","doi-asserted-by":"crossref","unstructured":"LeBel, M. & Spino, M. 1998 Pulse dosing versus continuous infusion of antibiotics. Clinical Pharmacokinetics14, 71\u201395.","DOI":"10.2165\/00003088-198814020-00002"},{"key":"key\n\t\t\t\t20170411035156_R17","doi-asserted-by":"crossref","unstructured":"Daenen, S. & de Vries-Hospers, H. 1988 Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime. Lanceti, 937.","DOI":"10.1016\/S0140-6736(88)91741-2"},{"key":"key\n\t\t\t\t20170411035156_R18","doi-asserted-by":"crossref","unstructured":"David, T. J. & Devlin, J. 1989 Continuous infusion of ceftazidime in cystic fibrosis. Lancet i, 1454\u20135.","DOI":"10.1016\/S0140-6736(89)90164-5"},{"key":"key\n\t\t\t\t20170411035156_R19","doi-asserted-by":"crossref","unstructured":"Kuzemko, J. & Crawford, C. 1989 Continuous infusion of ceftazidime in cystic fibrosis. Lancetii, 385.","DOI":"10.1016\/S0140-6736(89)90561-8"},{"key":"key\n\t\t\t\t20170411035156_R20","doi-asserted-by":"crossref","unstructured":"Mylotte, J., Aeschlimann, J. R. & Rotella, D. L. 1996Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infection Control and Hospital Epidemiology17 , 165\u20138.","DOI":"10.2307\/30142375"},{"key":"key\n\t\t\t\t20170411035156_R21","doi-asserted-by":"crossref","unstructured":"Mansur, A. J., Grinberg, M., Cardoso, A., Da Luz, P. L., Bellotti, G. & Pileggi, F. 1996 Determinants of prognosis in 300 episodes of infective endocarditis. Thoracic and Cardiovascular Surgeon44, 2\u201310.","DOI":"10.1055\/s-2007-1011974"},{"key":"key\n\t\t\t\t20170411035156_R22","doi-asserted-by":"crossref","unstructured":"Mylotte, M. M., McDermott, C. & Spooner, J. A. 1987 Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Reviews of Infectious Diseases9, 891\u2013907.","DOI":"10.1093\/clinids\/9.5.891"},{"key":"key\n\t\t\t\t20170411035156_R23","doi-asserted-by":"crossref","unstructured":"Benn, M., Hagelskjaer, L. H. & Tvede, M. 1997 Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. Journal of Internal Medicine242, 15\u201322.","DOI":"10.1046\/j.1365-2796.1997.00153.x"},{"key":"key\n\t\t\t\t20170411035156_R24","unstructured":"Lynn, B. 1971 Recent work on parenteral penicillins. Journal of Hospital Pharmacy29, 183\u201394."},{"key":"key\n\t\t\t\t20170411035156_R25","unstructured":"Craig, W. A. & Ebert, S. C. 1989 Protein binding and its significance in antibacterial therapy. Infectious Disease Clinics of North America 3,407\u2013 14."},{"key":"key\n\t\t\t\t20170411035156_R26","doi-asserted-by":"crossref","unstructured":"Leggett, J. E., Wolz, S. A. & Craig, W. A. 1989 Use of serum ultrafiltrate in the serum dilution test. Journal of Infectious Diseases 160, 616\u201323.","DOI":"10.1093\/infdis\/160.4.616"},{"key":"key\n\t\t\t\t20170411035156_R27","doi-asserted-by":"crossref","unstructured":"Graham, D. R., Kelderman, M. M., Klemm, L. W., Semenza, N. J. & Shafer, M. L. 1991 Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. American Journal of Medicine91, 95S\u2013100S.","DOI":"10.1016\/0002-9343(91)90351-W"},{"key":"key\n\t\t\t\t20170411035156_R28","doi-asserted-by":"crossref","unstructured":"Wood, C. A. & Wisniewski, R. M. 1994 \u03b2-Lactam versus glyco-peptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrobial Agents and Chemotherapy38, 1023\u20136.","DOI":"10.1128\/AAC.38.5.1023"},{"key":"key\n\t\t\t\t20170411035156_R29","doi-asserted-by":"crossref","unstructured":"Graninger, W., Wenisch, C. & Hasenhundl, M. 1995 Treatment of staphylococcal infections. Current Opinion in Infectious Diseases 8, S20\u20138.","DOI":"10.1097\/00001432-199503001-00005"},{"key":"key\n\t\t\t\t20170411035156_R30","unstructured":"Mortara, L. A. & Bayer, A. S. 1993Staphylococcus aureus bacteremia and endocarditis. Infectious Disease Clinics of North America 7,53\u2013 68."},{"key":"key\n\t\t\t\t20170411035156_R31","unstructured":"Grayson, M. L., Silvers, J. & Turnidge, J. 1995 Home intravenous antibiotic therapy: a safe and effective alternative to inpatient care. Medical Journal of Australia 162, 249\u201353."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/43\/1\/113\/13056629\/JAC431113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T23:54:54Z","timestamp":1512690894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/43.1.113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,1]]},"published-print":{"date-parts":[[1999,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/43.1.113","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}